Expression and responsiveness of P2Y2 receptors in human endometrial cancer cell lines.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 10566654)

Published in J Clin Endocrinol Metab on November 01, 1999

Authors

A C Katzur1, T Koshimizu, M Tomić, A Schultze-Mosgau, O Ortmann, S S Stojilkovic

Author Affiliations

1: Endocrinology and Reproduction Research Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892-4510, USA.

Articles by these authors

Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet (2007) 8.08

Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat (2013) 2.26

A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod (2005) 2.02

Gastroureteroplasty in a woman with bilateral ureteric strictures after pelvic radiotherapy. BJU Int (1999) 2.00

Paradoxical role of large-conductance calcium-activated K+ (BK) channels in controlling action potential-driven Ca2+ entry in anterior pituitary cells. J Neurosci (2001) 1.36

Dependence of pituitary hormone secretion on the pattern of spontaneous voltage-gated calcium influx. Cell type-specific action potential secretion coupling. J Biol Chem (2001) 1.32

High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines. J Clin Endocrinol Metab (1993) 1.22

Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. Hum Reprod (1999) 1.20

Mechanism of agonist-induced [Ca2+]i oscillations in pituitary gonadotrophs. J Biol Chem (1993) 1.07

Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study. Hum Reprod (2007) 1.05

Characterization of calcium signaling by purinergic receptor-channels expressed in excitable cells. Mol Pharmacol (2000) 1.03

Differential expression of ionic channels in rat anterior pituitary cells. Mol Endocrinol (2001) 1.01

Expression of gonadotropin-releasing hormone receptors and autocrine regulation of neuropeptide release in immortalized hypothalamic neurons. Proc Natl Acad Sci U S A (1993) 1.01

Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis. Ann Surg Oncol (2009) 1.01

High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines. Cancer Res (1993) 1.00

Identification of amino acid residues contributing to desensitization of the P2X2 receptor channel. J Biol Chem (1998) 0.99

Modeling of membrane excitability in gonadotropin-releasing hormone-secreting hypothalamic neurons regulated by Ca2+-mobilizing and adenylyl cyclase-coupled receptors. J Neurosci (2000) 0.99

Autocrine regulation of gonadotropin-releasing hormone secretion in cultured hypothalamic neurons. Endocrinology (1999) 0.98

Membrane potential regulates inositol 1,4,5-trisphosphate-controlled cytoplasmic Ca2+ oscillations in pituitary gonadotrophs. J Biol Chem (1994) 0.98

Expression of purinergic receptor channels and their role in calcium signaling and hormone release in pituitary gonadotrophs. Integration of P2 channels in plasma membrane- and endoplasmic reticulum-derived calcium oscillations. J Biol Chem (1996) 0.97

Effects of LHRH-analogues on mitogenic signal transduction in cancer cells. J Steroid Biochem Mol Biol (1998) 0.97

Contributions of the C-terminal domain to the control of P2X receptor desensitization. J Biol Chem (1999) 0.97

Paracrine changes in the peritoneal environment of women with endometriosis. Hum Reprod Update (1999) 0.95

Functional role of alternative splicing in pituitary P2X2 receptor-channel activation and desensitization. Mol Endocrinol (1998) 0.94

Dependence of hyperpolarisation-activated cyclic nucleotide-gated channel activity on basal cyclic adenosine monophosphate production in spontaneously firing GH3 cells. J Neuroendocrinol (2006) 0.93

Characterization of purinergic receptors and receptor-channels expressed in anterior pituitary cells. Endocrinology (2000) 0.93

Toxicity of aspartame and its diketopiperazine for Wistar rats by dietary administration for 104 weeks. Toxicology (1981) 0.93

Inhibition of rat testicular androgenesis by a polychlorinated biphenyl mixture aroclor 1248. Biol Reprod (2000) 0.93

Coordinate regulation of gonadotropin-releasing hormone neuronal firing patterns by cytosolic calcium and store depletion. Proc Natl Acad Sci U S A (1999) 0.92

Regulation of Ca2+-sensitive adenylyl cyclase in gonadotropin-releasing hormone neurons. Mol Endocrinol (2001) 0.91

Control of cytosolic free calcium in cultured human pancreatic beta-cells occurs by external calcium-dependent and independent mechanisms. Endocrinology (1994) 0.91

Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol. Hum Reprod (2005) 0.91

Spontaneous and receptor-controlled soluble guanylyl cyclase activity in anterior pituitary cells. Mol Endocrinol (2001) 0.90

Interactions of insulin-like growth factor-I, insulin and estradiol with GnRH-stimulated luteinizing hormone release from female rat gonadotrophs. Eur J Endocrinol (2001) 0.90

Expression of the lipid transporters ABCA3 and ABCA1 is diminished in human breast cancer tissue. Horm Metab Res (2009) 0.90

Growth-inhibitory actions of analogues of Luteinizing Hormone Releasing Hormone on tumor cells. Trends Endocrinol Metab (1997) 0.89

Modulation of the kinetics of inositol 1,4,5-trisphosphate-induced [Ca2+]i oscillations by calcium entry in pituitary gonadotrophs. Biophys J (1997) 0.89

Dependence of intracellular signaling and neurosecretion on phospholipase D activation in immortalized gonadotropin-releasing hormone neurons. Proc Natl Acad Sci U S A (1997) 0.88

Signaling by extracellular nucleotides in anterior pituitary cells. Trends Endocrinol Metab (2001) 0.88

Serum leptin concentrations throughout the menstrual cycle. Arch Gynecol Obstet (2000) 0.87

Coordinate actions of calcium and protein kinase-C in the expression of primary response genes in pituitary gonadotrophs. Endocrinology (1994) 0.87

Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers. Oncol Rep (2013) 0.87

Expression of the messenger RNAs for luteinizing hormone-releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma. Cancer Res (1995) 0.87

Autocrine regulation of calcium influx and gonadotropin-releasing hormone secretion in hypothalamic neurons. Biochem Cell Biol (2000) 0.87

[On the adrenocortical reserve test for infants using synthetic ACTH]. Horumon To Rinsho (1968) 0.87

Comet assay of cumulus cells and spermatozoa DNA status, and the relationship to oocyte fertilization and embryo quality following ICSI. Reprod Biomed Online (2006) 0.87

Control of action potential-driven calcium influx in GT1 neurons by the activation status of sodium and calcium channels. Mol Endocrinol (1999) 0.87

Roles of conserved ectodomain cysteines of the rat P2X4 purinoreceptor in agonist binding and channel gating. Physiol Res (2010) 0.86

The activation of an extracellular signal-regulated kinase by oestradiol interferes with the effects of trastuzumab on HER2 signalling in endometrial adenocarcinoma cell lines. Eur J Cancer (2003) 0.86

L-type Ca2+ channels mediate joint modulation by gamma-amino-butyric acid and glutamate of [Ca2+]i and neuropeptide secretion in immortalized gonadodropin-releasing hormone neurons. Neuroendocrinology (1995) 0.85

Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH). Arch Gynecol Obstet (2012) 0.85

Interaction of 99mTc-radiopharmaceuticals with transport proteins in human blood. Nucl Med Biol (1993) 0.85

GnRH agonists and antagonists in assisted reproduction: pregnancy rate. Reprod Biomed Online (2006) 0.85

Adiponectin differentially affects gene expression in human mammary epithelial and breast cancer cells. Br J Cancer (2008) 0.84

ApoA-I-binding protein (AI-BP) and its homologues hYjeF_N2 and hYjeF_N3 comprise the YjeF_N domain protein family in humans with a role in spermiogenesis and oogenesis. Horm Metab Res (2007) 0.83

Developmental and physiological aspects of Ca2+ signaling in agonist-stimulated pituitary gonadotrophs. Endocrinology (1994) 0.83

Sequential activation of phospholipase-C and -D in agonist-stimulated gonadotrophs. Endocrinology (1994) 0.83

Amplitude-dependent spike-broadening and enhanced Ca(2+) signaling in GnRH-secreting neurons. Biophys J (2000) 0.83

Involvement of inducible nitric oxide synthase in stress-impaired testicular steroidogenesis. J Endocrinol (1999) 0.82

Biphasic activation of cytosolic free calcium and LH responses by gonadotropin-releasing hormone. Biochem Biophys Res Commun (1988) 0.82

Effects of the phospholipase-C inhibitor, U73122, on signaling and secretion in pituitary gonadotrophs. Endocrinology (1995) 0.82

Wortmannin-sensitive and -insensitive steps in calcium-controlled exocytosis in pituitary gonadotrophs: evidence that myosin light chain kinase mediates calcium-dependent and wortmannin-sensitive gonadotropin secretion. Endocrinology (1997) 0.82

Dependence of stimulus-transcription coupling on phospholipase D in agonist-stimulated pituitary cells. Mol Biol Cell (1995) 0.81

Early onset and high prevalence of gestational diabetes in PCOS and insulin resistant women before and after assisted reproduction. Exp Clin Endocrinol Diabetes (2011) 0.81

[Age-related changes of serum testosterone, estrogens, LH and FSH from birth to puberty, and sex differences in the maturation of hypophyseal-gonadal system in childhood]. Horumon To Rinsho (1975) 0.81

Characterization of a plasma membrane calcium oscillator in rat pituitary somatotrophs. J Biol Chem (1999) 0.81

Neural discriminant analysis. IEEE Trans Neural Netw (2000) 0.81

Pulsatile gonadotropin-releasing hormone release and its regulation. Trends Endocrinol Metab (1996) 0.81

Characterization of calcium-mobilizing, purinergic P2Y(2) receptors in human ovarian cancer cells. Mol Hum Reprod (2000) 0.81

Calcium signaling in single rat Leydig cells. Endocrinology (1995) 0.81

Local regulation of gonadotroph function by pituitary gonadotropin-releasing hormone. Endocrinology (2000) 0.80

Expression of Ca(2+)-mobilizing endothelin(A) receptors and their role in the control of Ca(2+) influx and growth hormone secretion in pituitary somatotrophs. J Neurosci (1999) 0.80

Glutamate modulates [Ca2+]i and gonadotropin-releasing hormone secretion in immortalized hypothalamic GT1-7 neurons. Neuroendocrinology (1994) 0.80

LHRH might act as a negative autocrine regulator of proliferation of human ovarian cancer. Eur J Endocrinol (2000) 0.80

GnRH-induced cytosolic calcium oscillations in pituitary gonadotrophs: phase resetting by membrane depolarization. Biophys J (1995) 0.80

Dependence of the excitability of pituitary cells on cyclic nucleotides. J Neuroendocrinol (2012) 0.79

Dependence of soluble guanylyl cyclase activity on calcium signaling in pituitary cells. J Biol Chem (2001) 0.79

Role of alpha2-adrenoceptors in the local peripheral antinociception by carbamazepine in a rat model of inflammatory mechanical hyperalgesia. Methods Find Exp Clin Pharmacol (2007) 0.79

Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapeptyl Ovarian Cancer Study Group. Cancer (1996) 0.79

GnRH-induced calcium and current oscillations in gonadotrophs. Trends Endocrinol Metab (1996) 0.79

Amyloid-beta induces a caspase-mediated cleavage of P2X4 to promote purinotoxicity. Neuromolecular Med (2009) 0.79

Dependence of spontaneous electrical activity and basal prolactin release on nonselective cation channels in pituitary lactotrophs. Physiol Res (2012) 0.79

Plasma and follicular fluid concentrations of LHRH antagonist cetrorelix (Cetrotide) in controlled ovarian stimulation for IVF. Arch Gynecol Obstet (2002) 0.79

[Dermatomyositis and malignant disease--case report]. Reumatizam (2001) 0.78

Uncoupling of calcium mobilization and entry pathways in endothelin-stimulated pituitary lactotrophs. J Biol Chem (1997) 0.78

Acute effects of polychlorinated biphenyl-containing and -free transformer fluids on rat testicular steroidogenesis. Environ Health Perspect (2000) 0.78

Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer. Climacteric (2015) 0.78